Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens
Authors:
- J DownsJDJ Downs
- A GottoAGA Gotto
- M ClearfieldMCM Clearfield
- D GordonDGD Gordon
- T ManolioTMT Manolio
- U GoldbourtUGU Goldbourt
- E KaplinskyEKE Kaplinsky
- L MoyeLML Moye
- F SacksFSF Sacks
- M PfefferMPM Pfeffer
- C HawkinsCHC Hawkins
- E BraunwaldEBE Braunwald
- 1 June 1995
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 75 (16) , 1130-1134
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Assessing possible hazards of reducing serum cholesterolBMJ, 1994
- By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?BMJ, 1994
- Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA studyBMJ, 1994
- Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention TrialDiabetes Care, 1993
- Should there be a moratorium on the use of cholesterol lowering drugs?BMJ, 1992
- Might treatment of hypercholesterolaemia increase non-cardiac mortality?The Lancet, 1991
- Effects of Gemfibrozil and Other Fibric Acid Derivatives on Blood Lipids and LipoproteinsThe Journal of Clinical Pharmacology, 1991
- Expanded Clinical Evaluation of Lovastatin (EXCEL) Study ResultsArchives of internal medicine (1960), 1991
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MENThe Lancet, 1986